Globus Medical currently has an Earnings ESP of ... Additionally, some stocks may remain stable even if they end up missing the consensus estimate.

Globus Medical currently has an Earnings ESP of ... Additionally, some stocks may remain stable even if they end up missing the consensus estimate. Because of this, it's really important to ...

HighlightsTopline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February ...

Presently, there are few stable biomarkers available on a neuroanatomical level ... the Institutional Ethics Committee of China Medical University Hospital approved the study (IRB No. DMR98-IRB-290), ...

A study conducted by the Osservatorio Contract Logistics Gino Marchet reveals that while Italy's healthcare logistics sector ...

He has no past medical history, takes no regular medications ... should alert you to the possibility of a malignant aetiology, whereas stable and intermittent symptoms are more commonly associated ...

We report microelectrode data from the globus pallidus interna (GPi ... Dystonia Society UK, Action Medical Research, German National Academic Foundation. This was a retrospective analysis of ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Globus Medical (GMED – Research Report) and ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).